Surgical Equipment and Services |
| |
|
The US Food and Drug Administration (FDA) has approved Boston Scientific’s Carotid Wallstent Monorail Endoprosthesis for the treatment of patients with carotid artery disease who are at high risk for surgery. |
|
| |
|
Medtronic has launched the Talent Thoracic Stent Graft on the Xcelerant Delivery System to the US market. |
|
| |
|
Domingo Luciani Hospital has purchased a CyberKnife Robotic Radiosurgery System from Accuray for installation at their new oncology centre in Caracas, Venezuela. |
22 October 2008: Accuray |
| |
|
Five patients have received Terumo Heart’s DuraHeart Left Ventricular Assist System (LVAS), marking an early milestone in the US Pivotal Trial. |
|
| |
|
Barrx Medical has announced clinical trial results presented at the United European Gastroenterology Week (UEGW) in Vienna, Austria, October 18-22, 2008. |
|
| |
|
Medtronic has announced that more than 500,000 vertebral compression fractures (VCFs) have been treated with Kyphon Balloon Kyphoplasty since the minimally invasive procedure was commercialised in 2000. |
|
| |
|
Haukeland University Hospital in Bergen, Norway has installed a Leksell Gamma Knife Perfexion solution for non-invasive treatment of brain disorders. |
20 October 2008: Elekta |
| |
|
Medtronic has announced that the target lesion revascularization (TLR) rate for the company’s Endeavor drug‐eluting stent in the real‐world Danish trial, SORT OUT III, was 4.0 percent. |
|
| |
|
Boston Scientific’s WallFlex Biliary RX Stent (Ref 1) for the palliative treatment of malignant common bile duct strictures has been introduced in Europe. |
|
| |
|
Pioneer Surgical Technology has announced the successful human implantation of its new biologic inter-body spacer. |
|
| |
|
Boston Scientific has announced results from an analysis of the HORIZONS AMI trial, which is sponsored by the Cardiovascular Research Foundation (CRF) with research grant support from Boston Scientific and The Medicines Company, and is designed to determine the safety and efficacy of the Taxus Express2 Paclitaxel-Eluting Coronary Stent System compared to bare-metal stenting in patients experiencing an acute myocardial infarction (AMI), commonly referred to as a heart attack. |
|
| |
|
Boston Scientific has announced positive one-year results from the Intercontinental and European launch phases of its global Taxus OLYMPIA registry, the world's largest prospective, post-approval registry for a single drug-eluting stent (DES). |
|
| |
|
Medtronic has announced the US launch of the X-STOP PEEK IPD System, the first interspinous process decompression (IPD) device approved by the US FDA that offers a PEEK-Bone interface for treating the symptoms of lumbar spinal stenosis (LSS). |
|
| |
|
Doctors in the Netherlands have used Varian Medical Systems’ RapidArc technology to treat four early stage lung cancer patients in what is believed to be among the world's first treatments of their kind. |
15 October 2008: Varian |
| |
|
Pioneer Surgical Technology has released its FortrOss bone graft substitute to the US market. |
|
| |
|
Life Spine has introduced the ConquestPolyaxial Screw System, which is a top-loading thoracolumbar pedicle screw system that features a concerted locking mechanism that allows true inline compression and distraction of the construct. |
|
| |
|
Facet Solutions has completed a six month follow-up on 20 patients from its US IDE Pilot Study and the results show a 78 percent reduction in Oswestry Disability Index (ODI) scores, and an 80 percent reduction in Visual Analog Scores (VAS) for symptomatic leg pain. |
|
| |
|
St Jude Medical has announced US FDA and European CE Mark approval of the Angio-Seal Evolution Vascular Closure Device. |
|
| |
|
Of patients treated with the Endeavor Resolute drug-eluting stent (DES) from Medtronic in the RESOLUTE IDE trial only two required repeat procedures – a 1.5 percent rate of target lesion revascularization (TLR) – at two years following implant, according to data released at the Transcatheter Cardiovascular Therapeutics (TCT) symposium in Washington, DC, USA. |
|
| |
|
Comprehensive data has been announced by Boston Scientific from the Taxus ATLAS clinical programme, a series of global, prospective, multi-centre, single-arm, historically controlled trials, which evaluated the Taxus Liberte Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. |
|
| |
|
Boston Scientific has announced results from an analysis of almost 7,500 patients from its Taxus ARRIVE 1 and 2 registries, which are designed to confirm the performance of the Taxus Express2 Paclitaxel-Eluting Coronary Stent System in real-world practice. |
|
| |
|
Boston Scientific has received approval from the US FDA to market its second-generation Taxus Liberte Paclitaxel-Eluting Coronary Stent System. |
|
| |
|
North Shore Radiation Therapy in Huntington, New York, USA, has started treating cancer patients with Rapid Arc radiotherapy technology, a fast, precise form of treatment using advanced technology from Varian Medical Systems. |
09 October 2008: Varian |
| |
|
Archus Orthopedics has announced the first human use of its facet replacement technology to complement an artificial disc. |
|
| |
|
Brennen Medical has announced the nationwide availability in the USA of its XenMatriX product for soft tissue reconstruction. |
|
| |
| |
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 |
| |
